- New

DIACOM BP-Metformin + Glibenclamide is a combination medication used in the management of type 2 diabetes mellitus. It combines two antidiabetic agents: Metformin and Glibenclamide.
Description:
1. Formulation
o Metformin: 500 mg
o Glibenclamide: 5 mg
2. Indications
o Type 2 Diabetes Mellitus: This combination medication is used to improve glycemic control in adults with type 2 diabetes when diet and exercise alone are insufficient. It is typically prescribed when a single antidiabetic medication does not provide adequate control of blood glucose levels.
3. Age Groups
o Adults: This medication is generally prescribed for adults with type 2 diabetes.
o Elderly: Caution is required in elderly patients due to potential age-related changes in renal function and an increased risk of hypoglycemia.
4. Contraindications
o Hypersensitivity: Known hypersensitivity to Metformin, Glibenclamide, or any other component of the formulation.
o Type 1 Diabetes Mellitus: This medication is not indicated for type 1 diabetes.
o Diabetic Ketoacidosis: It should not be used in patients with diabetic ketoacidosis.
o Renal Impairment: Severe renal impairment or renal failure (e.g., creatinine clearance <30 mL/min).
o Hepatic Impairment: Significant liver disease or alcohol abuse.
o Severe Infection or Trauma: Conditions that can significantly alter glucose metabolism or may lead to an increased risk of hypoglycemia.
o Pregnancy and Lactation: Typically, the use of this medication is avoided during pregnancy and lactation unless clearly necessary, and alternative medications might be preferred.
Note: Always consult a healthcare provider for a full assessment and personalized recommendations based on individual health conditions and medical history.